Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Aligos Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +8 vs. Q3 2025
- Shares held
- 2.81M
- +159.5K (+6.0%) vs. Q3 2025
- Total value
- $26.2M
- +$208.1K (+0.8%) vs. Q3 2025
- New holders
- 13
- 9 more added
- Sold out
- 5
- 7 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $9 | 0.00% | +1 | New |
| BNP Paribas Arbitrage, SA | 3 | $28 | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 4 | $38 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 26 | $242 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 39 | $363 | 0.00% | −418−91.5% | Reduced |
| Triumph Capital Management | 135 | $1.26K | 0.00% | +135 | New |
| JPMorgan Chase & Co | 306 | $2.85K | 0.00% | −402−56.8% | Reduced |
| UBS Group AG | 364 | $3.39K | 0.00% | −15,818−97.8% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 0 | $3.50K | 0.00% | 0 | New |
| Global Retirement Partners, LLC | 400 | $3.73K | 0.00% | −400−50.0% | Reduced |
| Clear Street Markets LLC | 500 | $4.66K | 0.00% | +500 | New |
| Wells Fargo & Company | 1,500 | $14.0K | 0.00% | −1,670−52.7% | Reduced |
| Royal Bank of Canada | 2,125 | $20.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,520 | $23.5K | 0.00% | −8,764−77.7% | Reduced |
| Golden State Wealth Management, LLC | 2,674 | $24.9K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 4,972 | $46.3K | 0.00% | +4,972 | New |
| NorthCrest Asset Manangement, LLC | 10,000 | $84.1K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 10,000 | $93.2K | 0.00% | +9,000+900.0% | Added |
| HRT Financial LP | 11,374 | $106.0K | 0.00% | +11,374 | New |
| DRW Securities, LLC | 11,950 | $111.4K | 0.01% | +11,950 | New |
| Two Sigma Advisers, LP | 13,000 | $121.2K | 0.00% | +13,000 | New |
| BlackRock, Inc. | 13,040 | $121.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 13,108 | $122.2K | 0.00% | +11,194+584.8% | Added |
| Quest Partners LLC | 13,876 | $129.3K | 0.01% | +7,104+104.9% | Added |
| XTX Topco Ltd | 23,053 | $214.9K | 0.01% | +23,053 | New |
| Jane Street Group, LLC | 24,293 | $226.4K | 0.00% | +24,293 | New |
| Geode Capital Management, LLC | 47,741 | $445.1K | 0.00% | +661+1.4% | Added |
| Citadel Advisors LLC | 51,834 | $483.1K | 0.00% | +41,524+402.8% | Added |
| LPL Financial LLC | 66,000 | $615.1K | 0.00% | +10,880+19.7% | Added |
| Verition Fund Management LLC | 71,254 | $664.1K | 0.00% | +71,254 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $710.6K | 0.02% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 80,649 | $751.6K | 0.00% | +41,654+106.8% | Added |
| Baker Bros. Advisors LP | 83,055 | $774.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 85,444 | $796.3K | 0.00% | +30,425+55.3% | Added |
| SummitTX Capital, L.P. | 139,424 | $1.30M | 0.04% | +139,424 | New |
| Vanguard Group Inc | 200,395 | $1.87M | 0.00% | +28,706+16.7% | Added |
| Marshall Wace, LLP | 268,664 | $2.50M | 0.00% | +268,664 | New |
| Woodline Partners LP | 289,169 | $2.70M | 0.01% | −179,030−38.2% | Reduced |
| Sio Capital Management, LLC | 335,937 | $3.13M | 0.52% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 412,000 | $3.84M | 0.01% | 00.0% | Unchanged |
| Deep Track Capital, LP | 444,110 | $4.14M | 0.09% | 00.0% | Unchanged |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −203,113−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −30,493−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,107−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |